A phase-by-phase framework covering medical compliance, revenue quality, and clinical risk for buyers targeting cash-pay IV hydration businesses in the lower middle market.
Find IV Therapy Clinic Acquisition TargetsIV therapy clinics operate at the intersection of healthcare and lifestyle, creating unique due diligence demands. Buyers must validate medical director transferability, state-specific corporate practice of medicine compliance, compounding pharmacy relationships, and membership revenue retention before committing capital. This guide structures that process into three phases.
Confirm the clinic operates within state medical supervision laws and that all licenses, permits, and clinical agreements survive ownership transfer without triggering compliance violations.
Verify the medical director agreement is assignable to a new owner and the supervising physician is willing to remain post-close under a restructured, arms-length contract.
Engage a healthcare attorney to confirm the clinic's ownership and supervision structure complies with state-specific CPOM laws, which vary significantly across jurisdictions.
Audit all active clinic certificates, health department permits, and nurse licenses for currency, any violations, or conditions that could restrict operations post-acquisition.
Validate revenue sustainability by examining membership retention, visit frequency trends, customer concentration, and the accuracy of reported EBITDA against actual cash-pay collections.
Request month-over-month active member counts, churn rates, and average membership tenure for the past 24 months to assess recurring revenue stability and predictability.
Identify whether more than 20% of revenue derives from a single client, employer wellness contract, or seasonal event to assess transferability risk and revenue durability.
Analyze service mix and ticket size trends over 36 months to determine whether NAD+, peptide, or premium add-on adoption is growing or declining relative to basic hydration visits.
Evaluate malpractice exposure, compounding pharmacy compliance, staff licensing, and documented clinical protocols to quantify liability and operational continuity risk.
Obtain a full malpractice claims history, request state nursing and medical board complaint records, and confirm current professional liability insurance coverage limits for all providers.
Review all compounding pharmacy supplier contracts for 503B accreditation status and confirm IV formulations for NAD+, glutathione, and high-dose vitamins meet current FDA guidance.
Confirm written SOPs exist for all infusion protocols, adverse event response, and patient intake, and verify every administering nurse holds a current, unrestricted state RN or LPN license.
Verify the IV Therapy Clinic acquisition qualifies for SBA financing, the purchase price is supportable by the verified cash flow, and the deal structure protects the buyer's downside.
Confirm the IV Therapy Clinic meets SBA 7(a) eligibility requirements: the business is for-profit, U.S.-based, within SBA size standards, and the buyer meets personal financial requirements. Some industries have specific SBA restrictions — verify before LOI.
Model verified normalized EBITDA against projected SBA loan payments at current rates. A $1M SBA 7(a) loan at 10.5% over 10 years costs approximately $13,000/month. The IV Therapy Clinic must generate at least 1.25x debt service coverage after a market-rate manager salary to pass underwriting.
Confirm the seller note is properly subordinated to the SBA loan and goes on 24-month standby as required by SBA rules. If an earnout is included, define exact measurement metrics, time period, and dispute resolution process before signing the purchase agreement.
Before signing a Letter of Intent, request these documents from the seller. Missing or incomplete items are a red flag — not a reason to proceed without them.
Medical director dependency is the highest risk. If the owner serves as the sole supervising physician with no replacement identified, regulatory operations could collapse immediately post-close.
Yes, most IV therapy clinics qualify for SBA 7(a) loans covering 75–90% of the purchase price, provided the clinic has clean financials and the medical director agreement is transferable to the new owner.
Established clinics with membership programs and transferable medical director agreements typically trade at 3x–5.5x EBITDA, with premium multiples for multi-location operators or strong recurring revenue documentation.
Request 24 months of month-over-month active member counts, average revenue per member, and churn rates. Healthy programs show sub-10% monthly churn and 200+ active members generating predictable baseline revenue.
More IV Therapy Clinic Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers